Regulatory Pathways That Facilitated Timely Registration of a New Group A Meningococcal Conjugate Vaccine for Africa's Meningitis Belt Countries

Background. Through its normative and public health leadership roles, the World Health Organization (WHO) plays a key role in the availability of vaccine products in low-and middle-income countries. The recent introduction of a new group A meningococcal conjugate vaccine, PsA-TT (MenAfriVac), in Afr...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Clin Infect Dis
Hlavní autoři: Dellepiane, Nora, Akanmori, Bartholomew Dicky, Gairola, Sunil, Jadhav, Suresh S., Parker, Cathy, Rodriguez, Carmen, Srivastava, Swati
Médium: Artigo
Jazyk:Inglês
Vydáno: Oxford University Press 2015
Témata:
The Meningitis Vaccine Project: The Development, Licensure, Introduction, and Impact of a New Group a Meningococcal Conjugate Vaccine for Africa
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4639481/
https://ncbi.nlm.nih.gov/pubmed/26553671
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/civ491
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky